# Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

> **NCT02460081** · PHASE2 · WITHDRAWN · sponsor: **Celularity Incorporated**

## Conditions studied

- Diabetic Foot
- Peripheral Arterial Disease

## Interventions

- **DRUG:** PDA-002
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02460081
- **Lead sponsor:** Celularity Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-01-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was withdrawn prior to enrollment. Four subjects were screened but did not meet eligibility criteria; therefore, no subjects were enrolled. The study was not pursued further for administrative reasons.
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460081, "Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02460081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*